Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.05% | -177.18% | -32.91% | -109.75% | -940.00% |
| Total Depreciation and Amortization | -78.15% | -56.99% | -100.55% | -63.44% | -61.08% |
| Total Amortization of Deferred Charges | -- | -- | -66.67% | 167.50% | -35.00% |
| Total Other Non-Cash Items | -100.00% | -83.29% | -46.05% | -84.91% | 7,633.33% |
| Change in Net Operating Assets | -72.09% | -16.48% | 466.96% | 24.80% | 22.44% |
| Cash from Operations | -16.97% | -112.10% | -185.87% | -225.55% | -3,738.27% |
| Capital Expenditure | 92.31% | 95.49% | 21.05% | 76.92% | 94.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 50.00% | -185.71% | 54.69% |
| Cash from Investing | 97.62% | 96.34% | 37.50% | 73.25% | 85.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 71.43% | 150.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 271.76% | -121.00% | -186.67% | -242.39% | -1,340.38% |